Holen Sie sich die Stockscreener-App
10.49
1.06%
0.11
Handel nachbörslich:
10.54
0.05
+0.48%
Schlusskurs vom Vortag:
$10.38
Offen:
$10.36
24-Stunden-Volumen:
5.72M
Relative Volume:
1.14
Marktkapitalisierung:
$2.50B
Einnahmen:
$510.17M
Nettoeinkommen (Verlust:
$146.93M
KGV:
17.51
EPS:
0.599
Netto-Cashflow:
$27.51M
1W Leistung:
+13.28%
1M Leistung:
-30.76%
6M Leistung:
-29.83%
1J Leistung:
-49.83%
1-Tages-Spanne:
$10.31
$10.76
1-Wochen-Bereich:
$9.315
$10.76
52-Wochen-Spanne:
$7.2101
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
10.49 | 2.31B | 510.17M | 146.93M | 27.51M | 0.599 |
VRTX
Vertex Pharmaceuticals Inc
|
444.28 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
755.51 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
339.41 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
310.00 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating - PR Newswire
Technical Reactions to ADMA Trends in Macro Strategies - Stock Traders Daily
ADMA Biologics (ADMA) soars 11.6% as firm denies short seller allegations - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - ACCESS Newswire
ADMA Biologics, Inc. (ADMA) Jumps 7.6% to $10.44 - AlphaStreet
ADMA Biologics Price Target Cut to $24.00/Share From $30.00 by Mizuho - Moomoo
Aug Mood: Can ADMA Biologics Inc outperform in the next rally2026 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
ADMA Maintains Outperform Rating by Mizuho -- Price Target Lowered to $24 - GuruFocus
Risk Check: Why is ADMA Biologics Inc stock going up2026 Sentiment & Detailed Earnings Play Alerts - baoquankhu1.vn
ADMA Biologics Investigated for Alleged Securities Fraud - National Today
$ADMA Investigation Reminder: ADMA Biologics Investors are - GlobeNewswire
ADMA Biologics gains after refuting short seller claims - MSN
Cantor Fitzgerald Downgrades ADMA Biologics (ADMA) to Neutral, Here’s Why - Yahoo Finance
EV Market: Why is ADMA Biologics Inc stock going upBull Run & Momentum Based Trading Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics, Inc. (ADMA) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Gap Down: Is ADMA Biologics Inc subject to activist investor interestStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential - GlobeNewswire
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. - The Globe and Mail
Is ADMA Poised for Margin Growth and Supply Expansion in 2026? - TradingView — Track All Markets
A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations - Sahm
ADMA Biologics Faces Securities Fraud Probe Over Channel Stuffing Claims - National Today
ADMA Biologics Faces Securities Fraud Investigation Over Alleged Channel Stuffing - National Today
ADMA News Today | Why did ADMA Biologics stock go up today? - MarketBeat
Growth Value: Whats the fair value of ADMA Biologics Inc stock2026 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn
Growth Value: Is ADMA Biologics Inc attractive for institutional investors2026 Price Swings & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Adma Biologics (ADMA) Laps the Stock Market: Here's Why - Yahoo Finance
ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law - Business Wire
Advantage Alpha Capital Partners LP's ADMA Biologics Inc(ADMA) Holding History - GuruFocus
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. (NASDAQ:ADMA) Investors to Contact the Firm Regarding Ongoing Investigation - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Shareholders to Reach Out - ACCESS Newswire
ADMA Technical Analysis & Stock Price Forecast - Intellectia AI
Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - The Globe and Mail
Lowey Dannenberg, P.C. is Investigating ADMA Biologics - GlobeNewswire
ADMA Investor Announcement: ADMA Biologics Investigated - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
ADMA Biologics Under Investigation for Securities Violations - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA ... - Bluefield Daily Telegraph
ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA) - Seeking Alpha
Aberdeen Group Reduces ADMA Biologics Stake - National Today
ADMA Biologics Inc $ADMA Stock Holdings Lessened by Aberdeen Group plc - MarketBeat
ADMA INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ADMA Biologics, Inc. - ACCESS Newswire
Will Securities Probes Into Alleged Channel Stuffing Change ADMA Biologics' (ADMA) Narrative? - Sahm
ADMA stock downgraded by Cantor as ‘channel stuffing’ claims shake investor confidence - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over - GlobeNewswire
Shareholder News: ADMA Biologics (NASDAQ:ADMA) Drops 29% - GlobeNewswire
Allspring Global Investments Holdings LLC Decreases Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics slams short seller claims, highlights strong demand - MSN
ADMA Biologics extends selloff as Cantor downgrades after short report - MSN
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):